25.13
Elanco Animal Health Inc stock is traded at $25.13, with a volume of 3.34M.
It is up +1.37% in the last 24 hours and up +2.78% over the past month.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
See More
Previous Close:
$24.79
Open:
$24.85
24h Volume:
3.34M
Relative Volume:
0.67
Market Cap:
$12.49B
Revenue:
$4.45B
Net Income/Loss:
$205.00M
P/E Ratio:
62.82
EPS:
0.4
Net Cash Flow:
$372.00M
1W Performance:
-0.28%
1M Performance:
+2.78%
6M Performance:
+41.10%
1Y Performance:
+115.52%
Elanco Animal Health Inc Stock (ELAN) Company Profile
Name
Elanco Animal Health Inc
Sector
Phone
877-352-6261
Address
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ELAN
Elanco Animal Health Inc
|
25.13 | 12.32B | 4.45B | 205.00M | 372.00M | 0.40 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-22-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-21-25 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-19-25 | Upgrade | Argus | Hold → Buy |
| Oct-07-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-17-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jun-26-25 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-09-24 | Initiated | UBS | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Market Perform |
| Sep-19-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-05-24 | Upgrade | Stifel | Hold → Buy |
| Dec-19-23 | Initiated | Jefferies | Buy |
| Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Apr-20-23 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-18-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-16-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Sell |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Oct-28-21 | Downgrade | Stifel | Buy → Hold |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jun-15-21 | Upgrade | Cleveland Research | Underperform → Neutral |
| May-11-21 | Upgrade | Barclays | Underweight → Equal Weight |
| May-11-21 | Upgrade | Gabelli & Co | Hold → Buy |
| Apr-15-21 | Initiated | Stifel | Buy |
| Mar-22-21 | Downgrade | Gabelli & Co | Buy → Hold |
| Feb-26-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-09-20 | Downgrade | Argus | Buy → Hold |
| Nov-09-20 | Downgrade | Barclays | Overweight → Underweight |
| Aug-20-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-13-20 | Resumed | Credit Suisse | Neutral |
| Aug-04-20 | Resumed | Goldman | Buy |
| Jul-27-20 | Downgrade | Cleveland Research | Neutral → Underperform |
| Apr-02-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-20 | Initiated | Raymond James | Mkt Perform |
| Dec-19-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Nov-07-19 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-23-19 | Initiated | Barclays | Overweight |
| Aug-26-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-15-19 | Upgrade | UBS | Sell → Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Mar-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-13-19 | Resumed | Morgan Stanley | Equal-Weight |
| Feb-12-19 | Initiated | William Blair | Mkt Perform |
| Jan-23-19 | Initiated | UBS | Sell |
| Jan-15-19 | Initiated | Argus | Buy |
| Oct-15-18 | Initiated | Morgan Stanley | Equal-Weight |
View All
Elanco Animal Health Inc Stock (ELAN) Latest News
How currency fluctuations impact Elanco Animal Health Incorporated stockJuly 2025 PreEarnings & Smart Money Movement Alerts - mfd.ru
Here’s Why Elanco Animal Health Incorporated (ELAN) Declined in Q4 - MSN
DDD Partners LLC Acquires 108,941 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Will Elanco Animal Health Incorporated (5EA) stock benefit from sector leadershipStop Loss & Weekly High Return Stock Forecasts - mfd.ru
Chewy Settles Antitrust Claims Over Elanco Flea & Tick Meds - Law360
Elanco Announces Updates to Board of Directors - Finviz
Elanco Animal Health Board Members Not Seeking Reelection - Intellectia AI
Elanco Animal Health Board Updates Leadership - Intellectia AI
ELANCO ANIMAL HEALTH INCDAVID HOOVER RETIRES FROM ELANCO BOARD (NOT AS 'CHAIRMAN') - Intellectia AI
Livestock Gut Health Solutions Market to See Thriving Worldwide | Zoetis • Elanco Animal Health • Merck Animal Health - openPR.com
Why retail investors favor Elanco Animal Health Incorporated stockWeekly Market Report & Consistent Income Trade Recommendations - mfd.ru
PRISM MarketView Launches PetCare Index - GlobeNewswire Inc.
Can Elanco Animal Health Incorporated benefit from deglobalizationCEO Change & Weekly Top Gainers Alerts - mfd.ru
Pet Health Stock Barks Up A Beat; Shares Jump - Investor's Business Daily
State of Michigan Retirement System Invests $2.38 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Guidance Update: Will Elanco Animal Health Incorporated announce a stock splitJuly 2025 Selloffs & Stepwise Trade Execution Plans - mfd.ru
Wesbanco Bank Inc. Has $1.79 Million Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Skylands Capital LLC Lowers Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
What’s Elanco Animal Health Incorporated’s historical return2025 Winners & Losers & Intraday High Probability Alerts - mfd.ru
Animal Antibiotics and Antimicrobials Market to Reach US$ 17.85 - openPR.com
Elanco Animal Health (NYSE:ELAN) Hits New 1-Year HighWhat's Next? - MarketBeat
Animal Vaccine Market to Reach US$ 30.48 Billion by 2033 at 7.1% - openPR.com
Companion Animal Healthcare Market Is Going to Boom | Major - openPR.com
Here's What the Street Thinks About Elanco Animal Health Incorporated (ELAN) - Finviz
Here’s What the Street Thinks About Elanco Animal Health Incorporated (ELAN) - Yahoo Finance
Looking At The Narrative For Elanco Animal Health After New Launches And Analyst Revisions - Yahoo Finance
Guidance Update: What are Elanco Animal Health Incorporateds earnings expectationsOptions Play & Community Consensus Trade Signals - baoquankhu1.vn
Principal Financial Group Inc. Acquires 1,245,631 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
S P Trends: Whats Elanco Animal Health Incorporateds historical returnWeekly Trading Summary & Fast Moving Stock Watchlists - baoquankhu1.vn
Is Elanco Animal Health Incorporated (ELAN) at an Inflection Point? - Yahoo Finance
Animal Sedative Market Outlook 2026-2033: Growth Drivers, - openPR.com
Elanco Animal Health Inc (ELAN) Stock Price Up 3.16% on Feb 5 - GuruFocus
Elanco Animal Health stock hits 52-week high at 25.33 USD - Investing.com Canada
Elanco Animal Health (NYSE:ELAN) Sets New 12-Month HighHere's What Happened - MarketBeat
Johnson Fistel, PLLP Begins Investigation on Behalf of - GlobeNewswire
Stock Report: Is Elanco Animal Health Incorporated a speculative investmentEntry Point & Fast Entry Momentum Alerts - baoquankhu1.vn
Hardman Johnston Global Equity Strategy initiated a position in Elanco Animal Health (ELAN) - MSN
Independent Advisor Alliance Purchases 76,920 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Bank of America Securities Sticks to Their Buy Rating for Elanco Animal Health (ELAN) - The Globe and Mail
Mitsubishi UFJ Trust & Banking Corp Takes $1.44 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
UBS Group Forecasts Strong Price Appreciation for Elanco Animal Health (NYSE:ELAN) Stock - MarketBeat
Great Lakes Advisors LLC Takes $9.42 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Mutual of America Capital Management LLC Takes $4.62 Million Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Federated Hermes Inc. Grows Stock Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
Retirement Systems of Alabama Invests $12.10 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
INVESTOR ALERT AND NOTICE: Kaskela Law Firm Announces Investigation of Elanco Animal Health Inc. and Encourages Long-Term Elanco Investors with Losses to Contact the FirmELAN - ACCESS Newswire
Hardman Johnston Global Equity Strategy Initiated a Position in Elanco Animal Health (ELAN) - Insider Monkey
A Look At Elanco Animal Health (ELAN) Valuation After Recent Analyst Upgrades And Regulatory Approvals - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Has $6.10 Million Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
How Piper Sandler’s Upgrade and New Vet-Channel Approvals Will Impact Elanco Animal Health (ELAN) Investors - Yahoo Finance
Elanco Animal Health Inc Stock (ELAN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):